Acute embologenic phlebothrombosis in the inferior vena cava: long-term results
The analysis of long-term results of diagnosis and treatment in 1057 patients with embologenic phlebothrombosis in the inferior vena cava, including pregnant women (n=69) and postpartum women (n=33). Of particular interest is the study of genetic disorders of hemostasis that contribute to thrombosis in pregnant and postpartum women, thereby threatening the life of both mother and child. Observations of such patients within 5, 10, 15 or more years have confirmed a sufficient efficiency of that program of prevention and treatment of life-threatening situations developed by the authors, including the correction of genetic disorders of hemostasis, which led to the preservation of life and the safe delivery of all monitored patients in this group.